https://stock.noler.com/us/stock/allos-therapeutics-inc https://stock.noler.com/us/stock/allos-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/allos-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/allos-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/allos-therapeutics-inc/accrued-royalties-current-and-noncurrent https://stock.noler.com/us/stock/allos-therapeutics-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/allos-therapeutics-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/allos-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/allos-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/allos-therapeutics-inc/amended-reports-10-k https://stock.noler.com/us/stock/allos-therapeutics-inc/amended-reports-10-q https://stock.noler.com/us/stock/allos-therapeutics-inc/amortization https://stock.noler.com/us/stock/allos-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/allos-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/allos-therapeutics-inc/business-acquisition-share-price https://stock.noler.com/us/stock/allos-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/allos-therapeutics-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/allos-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/allos-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/allos-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/allos-therapeutics-inc/cost-of-goods-sold-amortization https://stock.noler.com/us/stock/allos-therapeutics-inc/cost-of-services-licenses-and-services https://stock.noler.com/us/stock/allos-therapeutics-inc/costs-and-expenses https://stock.noler.com/us/stock/allos-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/allos-therapeutics-inc/current-assets https://stock.noler.com/us/stock/allos-therapeutics-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/allos-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/allos-therapeutics-inc/deferred-revenue https://stock.noler.com/us/stock/allos-therapeutics-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/allos-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/allos-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/allos-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/allos-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/allos-therapeutics-inc/eps https://stock.noler.com/us/stock/allos-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/allos-therapeutics-inc/estimate-of-possible-loss https://stock.noler.com/us/stock/allos-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/allos-therapeutics-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/allos-therapeutics-inc/finite-lived-license-agreements-gross https://stock.noler.com/us/stock/allos-therapeutics-inc/held-to-maturity-securities-current https://stock.noler.com/us/stock/allos-therapeutics-inc/held-to-maturity-securities-noncurrent https://stock.noler.com/us/stock/allos-therapeutics-inc/income-tax https://stock.noler.com/us/stock/allos-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/allos-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/allos-therapeutics-inc/increase-decrease-in-accrued-interest-receivable-net https://stock.noler.com/us/stock/allos-therapeutics-inc/increase-decrease-in-accrued-investment-income-receivable https://stock.noler.com/us/stock/allos-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/allos-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/allos-therapeutics-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/allos-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/allos-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/allos-therapeutics-inc/inventory https://stock.noler.com/us/stock/allos-therapeutics-inc/inventory-finished-goods https://stock.noler.com/us/stock/allos-therapeutics-inc/inventory-gross https://stock.noler.com/us/stock/allos-therapeutics-inc/inventory-raw-materials https://stock.noler.com/us/stock/allos-therapeutics-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/allos-therapeutics-inc/inventory-work-in-process https://stock.noler.com/us/stock/allos-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/allos-therapeutics-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/allos-therapeutics-inc/license-and-services-revenue https://stock.noler.com/us/stock/allos-therapeutics-inc/long-term-investments https://stock.noler.com/us/stock/allos-therapeutics-inc/maturities-of-held-to-maturity-securities https://stock.noler.com/us/stock/allos-therapeutics-inc/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/allos-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/allos-therapeutics-inc/net-income https://stock.noler.com/us/stock/allos-therapeutics-inc/noncash-or-part-noncash-acquisition-fixed-assets-acquired https://stock.noler.com/us/stock/allos-therapeutics-inc/noncash-or-part-noncash-acquisition-inventory-acquired https://stock.noler.com/us/stock/allos-therapeutics-inc/nonoperating-gains-losses https://stock.noler.com/us/stock/allos-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/allos-therapeutics-inc/operating-income https://stock.noler.com/us/stock/allos-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/allos-therapeutics-inc/other-noncash-income-expense https://stock.noler.com/us/stock/allos-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/allos-therapeutics-inc/paid-in-capital-other https://stock.noler.com/us/stock/allos-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/allos-therapeutics-inc/payments-for-fees https://stock.noler.com/us/stock/allos-therapeutics-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/allos-therapeutics-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/allos-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/allos-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/allos-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/allos-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/allos-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/allos-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/allos-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/allos-therapeutics-inc/proceeds-from-income-tax-refunds https://stock.noler.com/us/stock/allos-therapeutics-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/allos-therapeutics-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/allos-therapeutics-inc/proceeds-from-sale-of-held-to-maturity-securities https://stock.noler.com/us/stock/allos-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/allos-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/allos-therapeutics-inc/public-float https://stock.noler.com/us/stock/allos-therapeutics-inc/receivables-net-current https://stock.noler.com/us/stock/allos-therapeutics-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/allos-therapeutics-inc/restricted-cash-and-investments-current https://stock.noler.com/us/stock/allos-therapeutics-inc/restructuring-and-related-cost-number-of-positions-eliminated https://stock.noler.com/us/stock/allos-therapeutics-inc/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/allos-therapeutics-inc/restructuring-charges https://stock.noler.com/us/stock/allos-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/allos-therapeutics-inc/revenue https://stock.noler.com/us/stock/allos-therapeutics-inc/sales-returns-and-allowances-goods https://stock.noler.com/us/stock/allos-therapeutics-inc/sales-revenue-goods-gross https://stock.noler.com/us/stock/allos-therapeutics-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-10-k https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-10-q https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-15-12g https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-25-nse https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-425 https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-8-k https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-ars https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-ct-order https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-def-14a https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-defa14a https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-defm14a https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-prer14a https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-regdex https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-sc-14d9 https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-sc-to-c https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-sc-to-t https://stock.noler.com/us/stock/allos-therapeutics-inc/sec-filings-sc14d9c https://stock.noler.com/us/stock/allos-therapeutics-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/allos-therapeutics-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/allos-therapeutics-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/allos-therapeutics-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/allos-therapeutics-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/allos-therapeutics-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/allos-therapeutics-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/allos-therapeutics-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/allos-therapeutics-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/allos-therapeutics-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/allos-therapeutics-inc/sga-expense https://stock.noler.com/us/stock/allos-therapeutics-inc/share-price https://stock.noler.com/us/stock/allos-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/allos-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/allos-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/allos-therapeutics-inc/short-term-investments https://stock.noler.com/us/stock/allos-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/allos-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/allos-therapeutics-inc/stock-compensation-allocation-of-recognized-period-costs-capitalized-amount https://stock.noler.com/us/stock/allos-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/allos-therapeutics-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/allos-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/allos-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/allos-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/allos-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/allos-therapeutics-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/allos-therapeutics-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/allos-therapeutics-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/allos-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/allos-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/allos-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/allos-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/allos-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/allos-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/allos-therapeutics-inc/tax-benefit-from-stock-options-exercised https://stock.noler.com/us/stock/allos-therapeutics-inc/total-assets https://stock.noler.com/us/stock/allos-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/allos-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted